Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Chinese University of Hong Kong
With
IBM China/Hong Kong Limited
Age
Any age
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Women who had undergone standard mammography including craniocaudal (CC) and mediolateral oblique (MLO) views..
Histopathology-proven diagnosis is available for patients with breast malignancy, including invasive breast cancer, carcinoma in situ, and borderline lesion et al.
As reference standard of benign nature, results from pathology or clinical long-term follow-up (\>=2 years) examinations are available for cases without breast malignancy.
You may not be if
Patients with concurring lesions on mammograms that may influence subsequent AI post-process.
Patients without available pathologic diagnosis or long-term follow-up (\>=2 years) examinations.
Patients who had undergone breast surgical intervention (e.g. lumpectomy and mammoplasty) prior to first mammography.
Patients diagnosed with other kinds of malignancy, concurrent with metastasis or infiltration/invasion to breast.
Clareo Health | Artificial Intelligence in Mammography-Based Breast Cancer Screening
